Brain microinjection can aid elucidation of the molecular substrates of complex behaviors, such as motivation. For this purpose rodents can serve as appropriate models, partly because the response to behaviorally relevant stimuli and the circuitry parsing stimulus-action outcomes is astonishingly similar between humans and rodents. In studying molecular substrates of complex behaviors, the microinjection of reagents that modify, augment, or silence specific systems is an invaluable technique. However, it is crucial that the microinjection site is precisely targeted in order to aid interpretation of the results. We present a method for the manufacture of surgical implements and microinjection needles that enables accurate microinjection and unlimited customizability with minimal cost. Importantly, this technique can be successfully completed in awake rodents if conducted in conjunction with other JoVE articles that covered requisite surgical procedures. Additionally, there are many behavioral paradigms that are well suited for measuring motivation. The progressive ratio is a commonly used method that quantifies the efficacy of a reinforcer to maintain responding despite an (often exponentially) increasing work requirement. This assay is sensitive to reinforcer magnitude and pharmacological manipulations, which allows reinforcing efficacy and/ or motivation to be determined. We also present a straightforward approach to program operant software to accommodate a progressive ratio reinforcement schedule.
Introduction
Rodents and humans respond in remarkably similar ways to behaviorally relevant stimuli [1] [2] [3] . This suggests that rodents are appropriate subjects for elucidating the molecular substrates of behavior and complex psychiatric conditions 4 . Understanding the molecular substrates of complex behavioral processes, such as motivation, frequently requires brain microinjection. Both the brain microinjection technique and a primary motivation assay will be presented here. Rats will be used as subjects, but these procedures can readily be adapted to well-handled mice. Included herein are procedures for the manufacture of the required cannulae, obturators (dummy cannulae or stylets), and microinjectors. The method presented is significantly more flexible and more cost-efficient than prefabricated implements. This flexibility will prove valuable when optimizing conditions. Importantly, because the microinjection procedure can be used to test a myriad of hypotheses; the techniques presented here should be broadly applicable. For example, receptor ligands can be microinjected to understand neurochemistry 3, 5, 6 ; cell-permeable peptides and small-molecules can be microinjected to understand intracellular signaling pathways [7] [8] [9] [10] ; toxins, ion channel blockers, or antagonist cocktails can be microinjected to understand circuitry 1, 11, 12 .
While the generic protocol presented here can be readily adapted by the user for their particular needs, the procedure is particularly well suited for behavioral assays since microinjection occurs in awake rodents that are only under mild hand restraint. No anesthesia or special restraints are required. This is possible because the brain itself lacks pain sensation. However, if anesthesia is not used, microinjection must occur through cannulae that were previously stereotaxically implanted. This is because nociceptors are present on the scalp, meninges, 13 which are the membranes surrounding the brain, and the periosteum, 14 which is the membrane covering the skull. It should be noted that microinjection under anesthesia is sometimes desirable. One example is when the virus is being injected, and one may wish to inject virus directly through either stainless steal needles 15 or glass pipettes because this can reduce tissue damage and improve transduction efficiency. 16, 17 The microinjectors described below can be modified for this purpose and suggestions on how to do this can be found in the Discussion. Because other JoVE articles have demonstrated stereotaxic brain cannula implantation, 18-20 these procedures will not be covered here.
We present these microinjection procedures together with an assay that quantifies motivation. Several rodent models of motivated behavior are currently in use, such as the runway box and barrier scaling. Here, we describe how to use an operant progressive ratio schedule of reinforcement to quantify motivation where operant responding is being maintained by a reinforcer. Responding on the progressive ratio is 11. Ream the inside diameter of both ends of the collar with a 26 G beveled needle (brown hub) to ensure that most of the burrs have been removed. Some small burrs will grab the microinjector wire and thus aid in gluing. 12. Slide one collar onto each microinjector tube ~2 cm from the end. 13 . Create a small pool of super glue in corner of a small weigh boat. 14. Use scrap cannula tubing cut to ~25 mm to apply a small amount of super glue to the microinjector tube ~5 mm from one end. Next, slide the collar over this super glue bead so that it is ~1 mm from the end of the microinjection tube. Cover both ends of the collar with glue. Note: Avoid a large accumulation of super glue on the collar, as it will prevent the plastic tubing from sealing around the microinjector. While it is important to avoid getting super glue on the open end of microinjector tubing, as this will make the microinjector unusable, it is also important to slide the collar as close to the end as possible to minimize void (non-injected) volume. 15. Lean the completed microinjector on the outside of another small weigh boat with the collar side up and allow to dry for 24 hr. 16 . Obtain an ~8 cm piece of microinjector plastic tubing (PE20 or equivalent), 1 ml syringe filled with sterile water, and 26 G beveled needle (brown hub). 17. Attach a 26 G (brown hub) needle to syringe and slide the cut tubing onto the needle, ensuring not to puncture the tube. 18. Slide the plastic tubing over the collar end of the dried, complete microinjector. 19. Squeeze the water-filled syringe plunger to test for patency.
Note: Water should spray very far and straight out of the microinjector tip. If the stream is not straight, the injection location will not be correct. The source of a sideways or diffuse spray is a poor break (step 1.4.5). A microinjector should not be used if the spray is sideways or diffuse. Saline should not be used, as it could clog the microinjector or needle. 20. Pull the syringe back in order to remove water from microinjector. Store in a dry, sealed vial; e.g., a 20 ml glass scintillation vial.
Note: Microinjectors can be autoclaved after manufacture with most super glues, 31 but this must be empirically determined. Alternative sterilization techniques include ethylene oxide and gamma irradiation.
Preparing for and Performing Microinjections
1. Obtain completed microinjectors, microinjector plastic tubing (PE20 or equivalent), microinjection pump, two small weigh boats, sterile water, 70% ethanol (v/v), acetone, two gastight 1 μl glass syringes with a blunt needle (25 G), cotton tipped wooden applicators, spare obturators, 1 ml syringe, 26 G (brown hub) needle, small curved forceps (style #7 is recommended), and lab wipes. 2. Preparing microinjectors for injection:
1. Bend completed microinjector 15 mm from the end opposite to the collar so that the angle between the two is ~95˚.
Note: A precise bend location is imperative for accurate injection location. Using #7 forceps (or similar) to grab the microinjector and bending upwards is useful. Always re-measure the length before performing microinjections. 2. Cut the plastic tubing (PE20) to ~70 cm and slide over microinjector collar.
Note: Adding tape tabs to one plastic tube near both the microinjector and loose end is useful when completing injections, especially when injecting two different solutions. Tabs are not recommended for both tubes as they become cumbersome during the injection.
3. Preparing pump for microinjections: 1. Power on pump.
2. Set diameter of microinjection needle, desired infusion rate, and target injection volume. Note: The infusion rate and injection volume is dependent upon experimental demands. This is elaborated on in the Discussion. Some pumps have syringe tables pre-loaded. If not, a syringe table can be found on the manufacture website(s). 3. Set pump mode to 'Volume' so that a precise volume is delivered automatically. If 'Pump' mode is selected instead, the experimenter must manually stop the pump. 4. Adjust the pump backstop to allow the syringe to fill to the injection volume plus an additional 0.2 μl.
4. Preparing microinjection syringe and microinjector for injection:
1. Lock each gastight microinjection syringe into the rack of the microinjection pump. 2. Place the tip of the gastight syringe into the sterile water contained in a small weigh boat and gently flutter the plunger to lubricate the internal wire. Evenly pull the plunger to the backstop on the pump to fill with water. 3. Slide the PE20 tubing that is connected to the microinjector (in step 2.2) onto a 26 G (brown hub) needle attached to a 1 ml syringe that is filled with sterile water. Spray sterile water through the microinjector, and inspect spray pattern and distance. Note: Water should spray very far and straight out of the microinjector tip. If the stream is not straight, the injection location will not be correct. 4. Place the sterilized microinjector onto a sterile field. 5. Slide the tubing off of the needle, keeping the microinjector tubing upright to prevent water from dripping out while also cutting the tubing below the area damaged by the needle. 6. Push the microinjection syringe plunger slightly forward to create a droplet on the end of the needle and slide the water-filled PE20 tubing (that is connected to the microinjector) onto the needle. Note: This will create a liquid-to-liquid connection that will allow appropriate backpressure that could dislodge a clog that could form at the tip of the microinjector. 7. Push the plunger completely forward to prepare for sample loading and ensure that no trace ethanol remains in the microinjector. 8. Check the setup for leaks by touching the water droplet that has formed at the tip of microinjector to a clean lab wipe multiple times. . This will ensure that the session will end if there is no activity on that operandum after the set threshold; i.e., the session will timeout after the animal withholds responding on the reinforcer-paired operandum for the set period of time. 5. Select Add 'Event Go To.' 6. Check the 'R' box, enter 1 into the first text box, select the release of appropriate operandum from first drop down box, and select 'S2' from TO S drop down box. Note: The created event may read similar to [ R (checked) After $ [1] Active GO P = 100%, TO S2]. This step ensures that upon release of the operandum (indicated by brackets above), that the state is reentered, thus resetting the Session timeout threshold (4.4.9.4). At this point, the state will exit when the progressive ratio contained in the list is completed (Step 4.4.9.2) or the session times out (Step 4.4.9.4). Thus, every time that the operandum is activated, it counts towards the progressive ratio. And, every time that the operandum is inactivated; e.g., the lever is released or the nose poke is exited, the Session timeout threshold (Step 4.4.9.4) is reset. Here, the state is exited upon either of two criteria. L$ is the progressive ratio schedule created in Step 4.3. Upon schedule completion, the state exits to State 3 (S3). Note that this criterion does not have an R, which allows the schedule to advance rather than beginning again upon each reentry into this state. The state can also exit after '$' minutes to state FIN. This is the predetermined timeout threshold after which the session will terminate if no responding occurs within this window. This is explained further in the Discussion. Lastly, the Session timeout threshold is reset upon every operandum release. Thus, ' [1] ' indicates release of the operandum '1'. 
Discussion
The procedure presented here is an efficient means to manufacture microinjection cannulae and microinjectors that will aid in elucidating the molecular substrates of motivated behavior. This method offers several advantages. First, by manufacturing one's own implants and microinjectors, novel experimental parameters can be rapidly optimized; i.e., one does not need to wait for custom made components to arrive. Second, due to the small diameter of the cannula, more cannulae can be simultaneously implanted. This shortens the required surgical time, which can improve survivability, and also allows multiple implants per animal. Third, the software used to control the operant chambers readily accommodates progressive ratio schedules since a fixed ratio paradigm can be rapidly converted to a progressive ratio paradigm by simply applying an event transition parameter list that contains the desired reinforcement schedule.
To be broadly useful, a generic microinjection procedure was presented that should be broadly applicable for the microinjection of nearly any reagent currently available. Consequently, we anticipate that this technique will continue to be of similar high utility in the future with minor modification. By changing only a few variables, this approach can be applied to a wide number of reagents. Parameters that would most commonly be manipulated include the length that the microinjector protrudes from the cannula, volume of injection, and rate of injection. For example, one may want the injector to protrude further from the cannula tip to avoid the glial scar that typically forms around chronic implants. Additionally, one may wish to inject a larger volume. For striatal virus microinjections, a volume of 1 μL is typically used and this volume is typically injected over a longer period of time (frequently 7 -10 min plus 3 -10 min additional diffusion time) compared to that used for pharmacological reagents (typically 0.3 -0.5 μL over 2 -3 min plus 1 -3 min additional diffusion time). The user should consult the literature and/ or empirically determine the parameters best suited for their needs. Regardless, the success of this procedure is critically dependent upon 4 variables: 1) cannula length, 2) microinjector length, 3) quality of microinjector spray pattern, and 4) the system integrity prior to injection. Because microinjection location is dependent on the depth that the microinjector protrudes from the cannula, it is imperative that both cannulae (Step 1.2.8) and microinjector length (post-bending, Step 2.2.1) are both precisely known and uniform between all subjects. This can easily be controlled by readily rejecting any implement that is not the required length at the final re-measuring. Moreover, the injection location can only be predicted if it occurs immediately beneath the guide cannula. Thus, any microinjector that does not spray a long, fine stream upon testing (Steps 2.4.6) should be rejected. A quality injection is also related to the integrity of the system prior to injection. If after dispensing all water from the injector (prior to filling with reagent) multiple spots are observed on the lab-wipe, then a leak needs to be remedied (Note on Step 2.4.8). Further, if the bubble (Step 2.4.9) that separates the drug from the water in the PE20 tubing is not one, single bubble (after filling the microinjector with Should one wish to microinject while the animal is in the stereotaxic frame there are three alternatives. First, one could increase the length of the microinjector collar such that it can be held firmly by the stereotaxic manipulator and also extend far enough to allow connection to PE20 tubing. Second, one could temporally implant a cannula and use the standard microinjector presented here. Third, one could use drawn and polished glass pipettes. 16, 17 A significant limitation of the procedure presented here is that it is best conducted in well-handled rats that are familiar with the procedure. Rats used for the data described in the results section required no special handling procedures because the same investigator handled the rats on a daily basis for over 2 months. This included daily observation and manipulation of the surgical implant for at least 2 weeks. However, rats can be rapidly habituated by a number of techniques that are used to prior to the pre-pulse inhibition assay, which can be affected by stress. These special habituation techniques have been nicely detailed previously. 43 In addition to these procedures, it is advisable that rats be habituated to the microinjection procedure where shortened microinjectors are used during 'sham' injections. During these sham injections, it is critical that the microinjector not protrude into the tissue in order to limit tissue damage. In other words, the microinjector should be bent no longer than 14 mm. Thus, the thorough habituation required for optimal implementation of this technique could be viewed as a limitation.
While several behavioral paradigms exist to measure motivation, the progressive ratio is commonly used to quantify the effort that the subject is willing to exert to obtain a reinforcer. The progressive ratio paradigm produces a measure known as breakpoint, which is often defined as the maximal number of lever presses in the last completed ratio; i.e., maximal responding that generated a reinforcer. 21 The progressive ratio is sensitive to reinforcer magnitude. For example, higher cocaine (or sucrose) doses produce a higher breakpoint and lower cocaine (or sucrose) doses yield a lower breakpoint. 21, 22 Accordingly, breakpoint is a routinely used proxy for motivation and/or reinforcing efficacy. 21, [23] [24] [25] [26] Because the intention of the breakpoint is to determine when the animal stops responding, an important parameter of the progressive ratio paradigm is session length. Finite session lengths can put a false cap on breakpoint values and this can be exacerbated by pre-treatments that abnormally decrease the rate of self-administration or that increase post-reinforcement pausing. This confound can be overcome by any number of approaches; e.g., sessions that terminate when the animal has withheld responding by some multiple of the average inter-infusion interval.
44
A more commonly applied variant of this approach is to terminate sessions once responding has been withheld by some empirically determined value that is held constant across subjects. We have provided the method to apply this approach in Step 4.4.9.11.
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